Abstract:Introduction: The U1 small nuclear RNA (snRNA) forms ribonucleoprotein particles (RNPs) such as U1 snRNP and U1-TAF15 snRNP. U1 snRNP is one of the most studied RNPs due to its critical role in pre-mRNA splicing in defining the 5 splice site (5ss) of every exon through direct interactions with sequences at exon/intron junctions. Recent reports support the role of U1 snRNP in all steps of transcription, namely initiation, elongation, and termination. Functions of U1-TAF15 snRNP are less understood, though it associates with the transcription machinery and may modulate pre-mRNA splicing by interacting with the 5ss and/or 5ss-like sequences within the pre-mRNA. An anti-U1 antisense oligonucleotide (ASO) that sequesters the 5 end of U1 snRNA inhibits the functions of U1 snRNP, including transcription and splicing. However, it is not known if the inhibition of U1 snRNP influences post-transcriptional regulation of pre-mRNA splicing through deep intronic sequences. Methods: We examined the effect of an anti-U1 ASO that sequesters the 5 end of U1 snRNA on transcription and splicing of all internal exons of the spinal muscular atrophy (SMA) genes, SMN1 and SMN2 . Our study was enabled by the employment of a multi-exon-skipping detection assay (MESDA) that discriminates against prematurely terminated transcripts. We employed an SMN2 super minigene to determine if anti-U1 ASO differently affects splicing in the context of truncated introns. Results: We observed substantial skipping of multiple internal exons of SMN1 and SMN2 triggered by anti-U1 treatment. Suggesting a role for U1 snRNP in interacting with deep intronic sequences, early exons of the SMN2 super minigene with truncated introns were resistant to anti-U1 induced skipping. Consistently, overexpression of engineered U1 snRNAs targeting the 5ss of early SMN1 and SMN2 exons did not prevent exon skipping caused by anti-U1 treatment. Discussion: Our results uncover a unique role of the U1 snRNA-associated RNPs in splicing regulation executed through deep intronic sequences. Findings are significant for developing novel therapies for SMA based on deep intronic targets.

[The role of the U1 snRNP complex in the regulation of gene expression: recent reports]

Nuclear Matrix Factor Hnrnp U/SAF-A Exerts a Global Control of Alternative Splicing by Regulating U2 Snrnp Maturation

U1 Snrnp Biogenesis Deffects In Neurodegenerative Diseases

The Arabidopsis U1 snRNP regulates mRNA 3′-end processing

Phylogenetic Comparison and Splicing Analysis of the U1 snRNP-specific Protein U1C in Eukaryotes

The USTC co-opts an ancient machinery to drive piRNA transcription in C. elegans

U1 snRNP-Specific U1C Acts as the Gatekeeper of the Survival of Motor Neurons (SMN) Complex in snRNP Biogenesis

U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes

A U 1 Snrnp – Specific Assembly Pathway Reveals the SMN Complex As a Versatile Hub for RNP Exchange

U7 snRNA: A tool for gene therapy

U1 snRNP regulates chromatin retention of noncoding RNAs

Phylogenetic comparison and splice site conservation of eukaryotic U1 snRNP-specific U1-70K gene family

U1 snRNP telescripting regulates a size–function-stratified human genome

Genome-wide RNA-binding analysis of the trypanosome U1 snRNP proteins U1C and U1-70K reveals cis/trans-spliceosomal network.

The Role of the U5 snRNP in Genetic Disorders and Cancer

RNA recognition by Npl3p reveals U2 snRNA-binding compatible with a chaperone role during splicing

Interaction of 7SK with the Smn complex modulates snRNP production

Identification of additional regulatory RNPs that impact rRNA and U6 snRNA methylation

RNA–protein interactions and control of mRNA stability in neurons

Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs